Karleen Oberton Insider Deal for 12,196 Shares of Hologic, Inc. (HOLX); TEGNA Inc. (TGNA) Covered By 8 Bullish Analysts Last Week

TEGNA Inc. (NYSE:TGNA) Logo

TEGNA Inc. (NYSE:TGNA) Ratings Coverage

Among 15 analysts covering Tegna Inc (NYSE:TGNA), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. Tegna Inc had 49 analyst reports since August 4, 2015 according to SRatingsIntel. Stephens upgraded the shares of TGNA in report on Wednesday, April 25 to “Buy” rating. As per Wednesday, November 23, the company rating was downgraded by JP Morgan. The rating was maintained by Benchmark on Monday, July 31 with “Buy”. The firm has “Hold” rating given on Monday, October 16 by Jefferies. Barclays Capital maintained the shares of TGNA in report on Monday, April 23 with “Underweight” rating. The firm has “Buy” rating by Noble Financial given on Wednesday, September 20. The rating was maintained by Argus Research on Monday, December 7 with “Buy”. On Friday, April 1 the stock rating was downgraded by Barclays Capital to “Underweight”. The stock has “Outperform” rating by FBR Capital on Tuesday, November 1. The firm has “Buy” rating by Benchmark given on Friday, August 19. See TEGNA Inc. (NYSE:TGNA) latest ratings:

25/04/2018 Broker: Stephens Rating: Buy Upgrade
23/04/2018 Broker: Barclays Capital Old Rating: Underweight New Rating: Underweight Old Target: $12 New Target: $11 Maintain
12/04/2018 Broker: Guggenheim Rating: Buy New Target: $16.0000 Maintain
03/04/2018 Broker: RBC Capital Markets Rating: Hold New Target: $14.0000 Maintain
20/03/2018 Broker: B. Riley & Co Old Rating: Neutral New Rating: Neutral Old Target: $17 New Target: $16 Maintain
05/03/2018 Broker: Barclays Capital Old Rating: Underweight New Rating: Underweight Old Target: $13 New Target: $12 Maintain
02/03/2018 Broker: Barclays Capital Rating: Sell New Target: $12.0
04/01/2018 Broker: Wells Fargo Rating: Buy New Target: $19.0 Upgrade
19/12/2017 Broker: Noble Financial Rating: Buy Maintain
14/11/2017 Broker: Noble Financial Rating: Buy Maintain

Among 18 analysts covering Hologic (NASDAQ:HOLX), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Hologic has $5300 highest and $40 lowest target. $47.71’s average target is 25.78% above currents $37.93 stock price. Hologic had 63 analyst reports since July 24, 2015 according to SRatingsIntel. On Monday, July 17 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Buy” rating on Monday, September 25 by Canaccord Genuity. The firm has “Buy” rating by Needham given on Tuesday, August 1. The rating was downgraded by Evercore to “Hold” on Wednesday, January 4. The firm has “Equal Weight” rating given on Wednesday, September 2 by Barclays Capital. Argus Research maintained the stock with “Buy” rating in Monday, August 3 report. Piper Jaffray maintained the shares of HOLX in report on Thursday, February 8 with “Buy” rating. RBC Capital Markets maintained Hologic, Inc. (NASDAQ:HOLX) rating on Friday, August 11. RBC Capital Markets has “Hold” rating and $4200 target. Jefferies maintained Hologic, Inc. (NASDAQ:HOLX) on Friday, May 26 with “Buy” rating. The firm has “Hold” rating by Craig Hallum given on Wednesday, October 21.

The stock increased 2.76% or $1.02 during the last trading session, reaching $37.93. About 4.60M shares traded or 74.42% up from the average. Hologic, Inc. (NASDAQ:HOLX) has declined 11.91% since May 5, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.

An insider of the company Hologic Inc, Karleen Oberton also its Corp. VP & Chief Acctg Officer, disclosed her insider activities with the DC-based SEC on May 4, 2018. As published in the document, Karleen had sold 12,196 shares of the company. The total insider trade was worth $487,840 U.S Dollars. At the time of the trade the price of a share was $40.0. Karleen now holds 9,623 shares accounting for 0.00% of the Company’s market cap

More important recent Hologic, Inc. (NASDAQ:HOLX) news were published by: Benzinga.com which released: “Leerink Downgrades Hologic After ‘Lower Quality’ Q2 Revenue Beat” on May 03, 2018, also Seekingalpha.com published article titled: “Hologic Looks Iffy For Now”, Benzinga.com published: “Hologic’s SculpSure Body Contouring Treatment Scores Distribution Win” on April 17, 2018. More interesting news about Hologic, Inc. (NASDAQ:HOLX) was released by: Streetinsider.com and their article: “Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS” with publication date: May 02, 2018.

Investors sentiment decreased to 0.74 in Q4 2017. Its down 0.14, from 0.88 in 2017Q3. It turned negative, as 57 investors sold Hologic, Inc. shares while 165 reduced holdings. 70 funds opened positions while 94 raised stakes. 264.36 million shares or 0.45% less from 265.54 million shares in 2017Q3 were reported. Nippon Life Global Investors Americas Inc invested in 88,800 shares. Reynders Mcveigh Management Limited Liability owns 140,336 shares. Hall Laurie J Trustee holds 2,993 shares. Td Asset Mngmt accumulated 870,442 shares or 0.05% of the stock. Tower Research Cap Ltd Liability (Trc) owns 0.02% invested in Hologic, Inc. (NASDAQ:HOLX) for 4,306 shares. Ontario Teachers Pension Plan Board holds 69,990 shares or 0.04% of its portfolio. Thrivent Finance For Lutherans owns 630,830 shares for 0.09% of their portfolio. Blackrock invested in 0.04% or 20.94 million shares. Moreover, Fil has 0.01% invested in Hologic, Inc. (NASDAQ:HOLX). Loomis Sayles & Ltd Partnership accumulated 339,386 shares. Connecticut-based Webster State Bank N A has invested 0.25% in Hologic, Inc. (NASDAQ:HOLX). Veritable L P has 0.01% invested in Hologic, Inc. (NASDAQ:HOLX). Lafleur Godfrey Ltd Liability Company stated it has 213,816 shares or 2.25% of all its holdings. Ledyard National Bank & Trust has 0% invested in Hologic, Inc. (NASDAQ:HOLX). Moreover, Deutsche Fincl Bank Ag has 0.04% invested in Hologic, Inc. (NASDAQ:HOLX).

Since February 13, 2018, it had 3 buys, and 1 insider sale for $682,999 activity. Dockendorff Charles J bought $504,400 worth of stock. 6,600 shares were bought by Nawana Namal, worth $250,023. Shares for $271,250 were sold by Bebo Allison P. $199,826 worth of stock was bought by Wendell Amy McBride on Wednesday, March 14.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $10.49 billion. It operates through four divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It has a 10.04 P/E ratio. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test.

The stock increased 2.87% or $0.29 during the last trading session, reaching $10.38. About 1.62 million shares traded. TEGNA Inc. (NYSE:TGNA) has declined 29.94% since May 5, 2017 and is downtrending. It has underperformed by 41.49% the S&P500.

TEGNA Inc., a media company, operates a portfolio of broadcast stations and digital sites; and provides marketing service solutions for businesses. The company has market cap of $2.24 billion. The firm operates 46 television stations in 38 markets that produce local programming, such as news, sports, and entertainment. It has a 8.24 P/E ratio. The Company’s marketing services business provides solutions for clients on multiple channels, including broadcast, online, and OTT.

Hologic, Inc. (NASDAQ:HOLX) Institutional Positions Chart